Cohort study on gestational diabetes and nutrition in pregnant women
Wenzhou Gestational Diabetes Cohort
This study is testing how diet and exercise affect blood sugar levels in pregnant women with gestational diabetes and how these factors relate to the health of both mothers and their babies.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Westlake University Academic / other |
| Locations | 1 site (Wenzhou, Zhejiang) |
| Trial ID | NCT05794152 on ClinicalTrials.gov |
What this trial studies
The Wenzhou Gestational Diabetes Cohort (WGDC) is a prospective cohort study focusing on women with gestational diabetes mellitus (GDM) during pregnancy and their offspring in Wenzhou, China. This study aims to assess the continuous blood glucose response to dietary intake and physical activity over a two-week period, utilizing objective measurements such as accelerometers and continuous glucose monitors. Additionally, it seeks to explore the relationship between these factors and adverse birth outcomes, as well as the long-term metabolic health of both mothers and their children. Participants will be followed throughout their pregnancy and beyond to gather comprehensive data on health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 years or older who are diagnosed with gestational diabetes between 24-28 weeks of gestation and plan to deliver at Wenzhou People's Hospital.
Not a fit: Patients with serious medical disorders, such as cancer, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to personalized nutritional and lifestyle recommendations for pregnant women with gestational diabetes, improving health outcomes for both mothers and their children.
How similar studies have performed: Other studies have shown success in using objective measurements for dietary and physical activity assessments in managing gestational diabetes, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 18 years or older * Women with GDM mainly at 24-28 weeks of gestation * Women intended to deliver at Wenzhou People's Hospital * Women intended to remain in Wenzhou with their child for ≥4 years Exclusion Criteria: * Women with cancer and other serious medical disorders
Where this trial is running
Wenzhou, Zhejiang
- Wenzhou People's Hospital — Wenzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Ju-Sheng Zheng, PhD — Westlake University
- Study coordinator: Ju-Sheng Zheng, PhD
- Email: zhengjusheng@westlake.edu.cn
- Phone: 86-0571-86915303
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.